titlesubmit dateissue date
Now showing items 1-20 of 66
A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities.
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies
Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
CCR5 structural plasticity shapes HIV-1 phenotypic properties
Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals.
Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India
Emergence of HIV-1 drug resistance mutations in mothers on treatment with a history of prophylaxis in Ghana
Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations
Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line.
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine
HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope.